1.82 USD
+0.01 (+0.55%)
We assign a fundamental rating of 4 out of 10 to SNYR. SNYR was compared to 36 industry peers in the Personal Care Products industry. Both the profitability and the financial health of SNYR get a neutral evaluation. Nothing too spectacular is happening here. SNYR is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SNYR was profitable.
In the past year SNYR has reported a negative cash flow from operations.
1.2 Ratios
Looking at the Return On Assets, with a value of 12.47%, SNYR belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
SNYR's Return On Invested Capital of 29.10% is amongst the best of the industry. SNYR outperforms 97.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.47% | ||
| ROE | N/A | ||
| ROIC | 29.1% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SNYR's Profit Margin of 7.46% is fine compared to the rest of the industry. SNYR outperforms 77.78% of its industry peers.
SNYR has a better Operating Margin (17.95%) than 91.67% of its industry peers.
In the last couple of years the Operating Margin of SNYR has grown nicely.
SNYR has a better Gross Margin (71.08%) than 66.67% of its industry peers.
SNYR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.95% | ||
| PM (TTM) | 7.46% | ||
| GM | 71.08% |
OM growth 3YN/A
OM growth 5Y22.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-0.29%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SNYR is creating value.
Compared to 1 year ago, SNYR has more shares outstanding
The number of shares outstanding for SNYR has been increased compared to 5 years ago.
The debt/assets ratio for SNYR has been reduced compared to a year ago.
2.2 Solvency
SNYR has an Altman-Z score of 1.23. This is a bad value and indicates that SNYR is not financially healthy and even has some risk of bankruptcy.
SNYR's Altman-Z score of 1.23 is on the low side compared to the rest of the industry. SNYR is outperformed by 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.23 |
ROIC/WACC2.55
WACC11.41%
2.3 Liquidity
SNYR has a Current Ratio of 5.35. This indicates that SNYR is financially healthy and has no problem in meeting its short term obligations.
SNYR has a Current ratio of 5.35. This is amongst the best in the industry. SNYR outperforms 91.67% of its industry peers.
A Quick Ratio of 4.79 indicates that SNYR has no problem at all paying its short term obligations.
SNYR has a better Quick ratio (4.79) than 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.35 | ||
| Quick Ratio | 4.79 |
3. Growth
3.1 Past
The earnings per share for SNYR have decreased strongly by -67.60% in the last year.
SNYR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.57%.
SNYR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.48% yearly.
EPS 1Y (TTM)-67.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-88.04%
Revenue 1Y (TTM)-18.57%
Revenue growth 3YN/A
Revenue growth 5Y3.48%
Sales Q2Q%12.4%
3.2 Future
Based on estimates for the next years, SNYR will show a very strong growth in Earnings Per Share. The EPS will grow by 28.84% on average per year.
SNYR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.96% yearly.
EPS Next Y-25%
EPS Next 2Y-7.2%
EPS Next 3Y28.84%
EPS Next 5YN/A
Revenue Next Year0.72%
Revenue Next 2Y24.29%
Revenue Next 3Y19.96%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 6.28, the valuation of SNYR can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of SNYR indicates a rather cheap valuation: SNYR is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, SNYR is valued rather cheaply.
With a Price/Forward Earnings ratio of 5.76, the valuation of SNYR can be described as very cheap.
97.22% of the companies in the same industry are more expensive than SNYR, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, SNYR is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.28 | ||
| Fwd PE | 5.76 |
4.2 Price Multiples
SNYR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SNYR is cheaper than 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.12 |
4.3 Compensation for Growth
SNYR's earnings are expected to grow with 28.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.2%
EPS Next 3Y28.84%
5. Dividend
5.1 Amount
No dividends for SNYR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:SNYR (1/13/2026, 8:00:02 PM)
1.82
+0.01 (+0.55%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners14.58%
Inst Owner ChangeN/A
Ins Owners6.97%
Ins Owner Change0%
Market Cap20.48M
Revenue(TTM)34.59M
Net Income(TTM)2.58M
Analysts82.86
Price Target7.14 (292.31%)
Short Float %0.35%
Short Ratio0.37
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)53.19%
Min EPS beat(2)-1.96%
Max EPS beat(2)108.33%
EPS beat(4)2
Avg EPS beat(4)14.06%
Min EPS beat(4)-90.2%
Max EPS beat(4)108.33%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-27.06%
Min Revenue beat(2)-27.95%
Max Revenue beat(2)-26.16%
Revenue beat(4)0
Avg Revenue beat(4)-17.48%
Min Revenue beat(4)-27.95%
Max Revenue beat(4)-4.54%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-30%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-92.31%
EPS NY rev (1m)0%
EPS NY rev (3m)-34.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-30.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-18.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.28 | ||
| Fwd PE | 5.76 | ||
| P/S | 0.59 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.12 |
EPS(TTM)0.29
EY15.93%
EPS(NY)0.32
Fwd EY17.37%
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS3.07
BVpS-0.73
TBVpS-0.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.47% | ||
| ROE | N/A | ||
| ROCE | 36.83% | ||
| ROIC | 29.1% | ||
| ROICexc | 30.97% | ||
| ROICexgc | 31.33% | ||
| OM | 17.95% | ||
| PM (TTM) | 7.46% | ||
| GM | 71.08% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y22.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-0.29%
F-Score3
Asset Turnover1.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.02 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 1.88 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.35 | ||
| Quick Ratio | 4.79 | ||
| Altman-Z | 1.23 |
F-Score3
WACC11.41%
ROIC/WACC2.55
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-88.04%
EPS Next Y-25%
EPS Next 2Y-7.2%
EPS Next 3Y28.84%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.57%
Revenue growth 3YN/A
Revenue growth 5Y3.48%
Sales Q2Q%12.4%
Revenue Next Year0.72%
Revenue Next 2Y24.29%
Revenue Next 3Y19.96%
Revenue Next 5YN/A
EBIT growth 1Y-46.32%
EBIT growth 3YN/A
EBIT growth 5Y26.96%
EBIT Next Year47.57%
EBIT Next 3Y33.07%
EBIT Next 5YN/A
FCF growth 1Y-1239.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1239.06%
OCF growth 3YN/A
OCF growth 5YN/A
SYNERGY CHC CORP / SNYR FAQ
Can you provide the ChartMill fundamental rating for SYNERGY CHC CORP?
ChartMill assigns a fundamental rating of 4 / 10 to SNYR.
What is the valuation status of SYNERGY CHC CORP (SNYR) stock?
ChartMill assigns a valuation rating of 6 / 10 to SYNERGY CHC CORP (SNYR). This can be considered as Fairly Valued.
What is the profitability of SNYR stock?
SYNERGY CHC CORP (SNYR) has a profitability rating of 4 / 10.
What are the PE and PB ratios of SYNERGY CHC CORP (SNYR) stock?
The Price/Earnings (PE) ratio for SYNERGY CHC CORP (SNYR) is 6.28 and the Price/Book (PB) ratio is -2.48.
How financially healthy is SYNERGY CHC CORP?
The financial health rating of SYNERGY CHC CORP (SNYR) is 4 / 10.